CorePharma is a leading U.S.-based contract development and manufacturing organization (CDMO), dedicated to delivering high-quality pharmaceuticals across diverse therapeutic categories. We provide comprehensive, end-to-end solutions—from early-stage drug development to commercial launch and beyond.
With a proven track record of regulatory excellence, CorePharma operates 4 state-of-the-art, FDA- and DEA-registered facilities, spanning 150,000 square feet. Our advanced development, analytical, clinical, and commercial manufacturing and packaging capabilities support an annual production capacity of 5 billion dosage units.
Backed by industry-leading lead times, we accelerate your journey from the lab to the clinic—and ultimately to the patient. At CorePharma, we are committed to being your concept to commercial CDMO platform for success.
Growing since 1968, Prime is focused on making a positive difference in the healthcare outcomes for people around the globe. We pride ourselves as a customer-centric company. We truly understand our customer’s needs and work hard to fulfill them at our highest capacity. It has been our benchmark since we started operations in 1968.
Prime Pharma has two manufacturing plants and support R&D centers. We are present in over 50+ countries and have successfully registered 400+ dossiers. The company has international offices in Vietnam, Spain, UAE, and Costa Rica.
Our manufacturing processes produce a comprehensive, diverse, and highly complementary portfolio of generics and specialty medicines. Further, to provide comprehensive services along with collaborative support in terms of complete product development, dossier preparations, and technology transfer to the global markets, we have ventured into R&D services since 2016.
EU-GMP facilities, USFDA facilities, PICS-approved facilities, WHO-GMP facilities
Presence in Europe, Latin & Central America, Asia-Pacific, Africa, CIS, and MENA regions.